Physician
Rheumatology
Dr. Florin I. Niculescu, MD
|
|
Give Review
Florin I. Niculescu practices Rheumatology. Doctor Florin I. Niculescu, MD is a published doctor and has 34 publications published. The lastest was: 'Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes.' He is registered with Medicare.
Publications
- Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.
- Membrane attack by complement: the assembly and biology of terminal complement complexes.
- C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte Cell cycle activation and dedifferentiation.
- TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.
- Response gene to complement 32 is required for C5b-9 induced Cell cycle activation in endothelial Cells.
- Complement C5 regulates the expression of insulin-like growth factor binding proteins in Chronic experimental allergic encephalomyelitis.
- Dendritic Cells are abundant in non-lesional gray matter in multiple sclerosis.
- The complement system in central nervous system Diseases.
- Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
- C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
- Oligodendrocyte Cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.
- C5b-9-induced endothelial Cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1.
- C5b-9 terminal complex protects oligodendrocytes from apoptotic Cell death by inhibiting caspase-8 processing and up-regulating FLIP.
- The role of the complement system in innate immunity.
- The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.
- C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection.
- Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host Disease.
- Overexpression of RGC-32 in colon cancer and other tumors.
- The role of c5b-9 terminal complement complex in activation of the Cell cycle and transcription.
- Two new actions of sea nettle (Chrysaora quinquecirrha) nematocyst venom: studies on the mechanism of actions on complement activation and on the central nervous system.
- The role of complement activation in atherosclerosis.
- Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.
- Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis.
- C5b-9 terminal complement complex assembly on apoptotic Cells in human arterial wall with atherosclerosis.
- Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes.
- Association of complement inhibitors with connective tissue matrix in atherosclerotic lesions.
- Low-dose exposure to inorganic mercury accelerates Disease and mortality in acquired murine lupus.
- Pathogenic T Cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
- RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle Cells into S-phase.
- Role of the C5b-9 complement complex in Cell cycle and apoptosis.
- Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes.
- Inflammation, aspirin, and the risk of cardiovascular Disease.
- Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle Disease virus.
Schools
Institute Of Medicine amp Pharmacy 39carol Davila39
University MD Som
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Antiphospholipid Syndrome (APS)
- Arthritis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Education
-
University of Maryland -
Iuliu Hatieganu University of Medicine and Pharmacy
Drug Facts
| NPI NUMBER | 1306930805 | |
| NPPES Provider LastName | NICULESCU | |
| NPPES Provider FirstName | FLORIN | |
| NPPES Provider ZIPCode | 21784 | |
| NPPES Provider State | MD | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 1179.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 1.02 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306930805 |
| Last Name Of The Provider | NICULESCU |
| First Name Of The Provider | FLORIN |
| View All |
Similar Doctors
|
|
Dr. Teodora M. Niculescu, MD
 This Doctor is OpenDoctor Recommended.
|